Geneos Wealth Management’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.6K Hold
3,000
– – ﹤0.01% 1514
2026
Q2
$95.6K Hold
3,000
– – ﹤0.01% 1225
2026
Q1
$73.7K Hold
3,000
– – ﹤0.01% 1281
2025
Q4
$56.6K Hold
3,000
– – ﹤0.01% 1349
2025
Q3
$44.6K Hold
3,000
– – ﹤0.01% 1429
2025
Q2
$39.9K Hold
3,000
– – ﹤0.01% 1699
2025
Q1
$30.3K Hold
3,000
– – ﹤0.01% 1732
2024
Q4
$30.8K Buy
+3,000
New +$36.9K ﹤0.01% 1532

Other funds holding CSTM

Geneos Wealth Management's CSTM Position: Q3 2026 in Review

Geneos Wealth Management held its Constellium (CSTM) position steady in Q3 2026 at 3,000 shares worth $72.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

Geneos Wealth Management first reported a position in CSTM in Q4 2024 and has held it in 8 quarters since. The position peaked at $95.6K in Q2 2026. 166 funds tracked by Wall St. Rank hold CSTM as of Q3 2026.

  • Geneos Wealth Management held 3,000 shares of Constellium worth $72.6K as of Q3 2026.
  • Geneos Wealth Management left its Constellium share count unchanged in Q3 2026.
  • Constellium made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #1514 holding.
  • Geneos Wealth Management first reported a position in Constellium in Q4 2024 and has held it in 8 quarters since.
  • Geneos Wealth Management's Constellium position peaked at $95.6K in Q2 2026.
  • 166 funds tracked by Wall St. Rank held Constellium as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.